TABLE 1.
Characteristic | All patients |
---|---|
[N = 754] | |
Median age, years | 66 |
Sex | |
Female | 518 (69) |
Male | 236 (31) |
Race | |
White | 503 (67) |
Black | 130 (17) |
Other | 121 (16) |
Charlson–Deyo score | |
0 | 538 (71) |
1 | 157 (21) |
≥ 2 | 59 (8) |
Tumor histology | |
Neuroendocrine carcinoma | 464 (62) |
Small cell neuroendocrine carcinoma | 217 (29) |
Large cell neuroendocrine carcinoma | 67 (9) |
Median tumor size, mm | 26 |
AJCC stagea | |
I | 205 (27) |
II | 77 (10) |
III | 121 (16) |
IV | 295 (39) |
Positive regional nodesa | |
Yes | 111 (15) |
No | 72 (47) |
Tumor gradea | |
1 | 93 (12) |
2 | 21 (3) |
3 or undifferentiated | 312 (41) |
Site of metastasis | |
Liver | 126 (17) |
Bone | 10 (1) |
Lung | 7 (1) |
Brain | 5 (1) |
Unspecified | 147 (19) |
Data are expressed as n (%)
NETs neuroendocrine tumors, AJCC American Joint Committee on Cancer
Missing data were omitted